Tacrolimus and cyclosporine A show similar efficacy in long-term survival and relapse reduction in AML post-transplant patients. No significant differences were found in leukemia-free survival, ...
Credit: FDA. The BX rating indicates that the data are insufficient to show that the product provides the same therapeutic effect as Prograf. The Food and Drug Administration (FDA) has changed the ...
LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--Nexus Pharmaceuticals, LLC announces the U.S Food and Drug Administration (FDA) approval of Tacrolimus Injection 5 mg/mL. Nexus’ Tacrolimus Injection is the first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback